191 related articles for article (PubMed ID: 30365107)
1. Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics.
Xie ZC; Huang JC; Zhang LJ; Gan BL; Wen DY; Chen G; Li SH; Yan HB
Mol Med Rep; 2018 Dec; 18(6):5630-5646. PubMed ID: 30365107
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma.
Li X; Qin M; Huang J; Ma J; Hu X
Mol Med Rep; 2019 Jun; 19(6):5063-5078. PubMed ID: 31059033
[TBL] [Abstract][Full Text] [Related]
3. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR‑224‑5p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in silico analyses.
Gan BL; Zhang LJ; Gao L; Ma FC; He RQ; Chen G; Ma J; Zhong JC; Hu XH
Oncol Rep; 2018 Dec; 40(6):3171-3188. PubMed ID: 30542718
[TBL] [Abstract][Full Text] [Related]
5. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
Yan HB; Zhang Y; Cen JM; Wang X; Gan BL; Huang JC; Li JY; Song QH; Li SH; Chen G
Med Sci Monit; 2018 Jul; 24():4807-4822. PubMed ID: 29997385
[TBL] [Abstract][Full Text] [Related]
6. Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.
Wang JY; Huang JC; Chen G; Wei DM
Mol Med Rep; 2018 Apr; 17(4):5013-5020. PubMed ID: 29393467
[TBL] [Abstract][Full Text] [Related]
7. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
9. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
[TBL] [Abstract][Full Text] [Related]
10. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis.
Lin J; Wu G; Zhao Z; Huang Y; Chen J; Fu C; Ye J; Liu X
Mol Med Rep; 2018 Dec; 18(6):5594-5602. PubMed ID: 30365099
[TBL] [Abstract][Full Text] [Related]
14. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
Guan Y; Wu Y; Liu Y; Ni J; Nong S
Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑512‑3p is upregulated, and promotes proliferation and cell cycle progression, in prostate cancer cells.
Rao Z; He Z; He Y; Guo Z; Kong D; Liu J
Mol Med Rep; 2018 Jan; 17(1):586-593. PubMed ID: 29115469
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G
Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
[TBL] [Abstract][Full Text] [Related]
19. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
[TBL] [Abstract][Full Text] [Related]
20. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
Huang W; Kang XL; Cen S; Wang Y; Chen X
Genet Test Mol Biomarkers; 2015 Sep; 19(9):469-75. PubMed ID: 26247873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
